Table 2 Deferiprone analysis using the validated probe in patient EBC samples and recovery experiments.
No. | Gender | Age (year) | Added (mg. Lāā1) | Found (mg. Lāā1) | Recovery (%) |
|---|---|---|---|---|---|
1 | Female | 30 | ā | 0.062 | ā |
0.1 | 0.163 | 101.0 | |||
0.2 | 0.375 | 106.0 | |||
2 | Female | 20 | ā | 0.094 | ā |
0.1 | 0.191 | 97.0 | |||
0.2 | 0.390 | 99.5 | |||
3 | Female | 50 | - | 0.042 | ā |
0.1 | 0.143 | 101.0 | |||
0.2 | 0.245 | 102.0 | |||
4 | Male | 25 | ā | 0.081 | ā |
0.1 | 0.18 | 99.0 | |||
0.2 | 0.37 | 95.0 | |||
5 | Male | 18 | ā | 0.118 | ā |
0.1 | 0.216 | 98.0 | |||
0.2 | 0.412 | 98.0 | |||
6 | Male | 63 | ā | 0.095 | ā |
0.1 | 0.191 | 96.0 | |||
0.2 | 0.292 | 98.5 |